Other
Cumulative Cost Basis
ResMed Cumulative Cost Basis increased by 2.6% to $1.35B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.2%, from $1.23B to $1.35B. Over 4 years (FY 2021 to FY 2025), Cumulative Cost Basis shows an upward trend with a 3.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2021
Last reportedQ1 2026
How to read this metric
Provides a stable reference point for the scale of the bank's investment activities and historical capital deployment.
Detailed definition
The cumulative cost basis represents the original purchase price or historical cost of assets or liabilities before any...
Peer comparison
Universal accounting concept used by all financial institutions to track historical investment scale.
Metric ID:
cumulative_cost_basisHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.09B | $1.08B | $1.11B | $1.17B | $1.13B | $1.11B | $1.20B | $1.18B | $1.21B | $1.20B | $1.27B | $1.26B | $1.27B | $1.32B | $1.21B | $1.23B | $1.26B | $1.29B | $1.31B | $1.35B |
| QoQ Change | — | -0.1% | +2.5% | +4.9% | -2.9% | -2.1% | +8.4% | -1.4% | +1.9% | -0.3% | +5.3% | -0.8% | +1.5% | +3.9% | -8.3% | +1.6% | +1.9% | +2.4% | +2.0% | +2.6% |
| YoY Change | — | — | — | — | +4.2% | +2.2% | +8.0% | +1.6% | +6.6% | +8.5% | +5.5% | +6.1% | +5.7% | +10.2% | -4.1% | -1.9% | -1.5% | -2.9% | +8.1% | +9.2% |
Range$1.08B – $1.35B
CAGR+4.6%
Avg YoY Growth+4.1%
Median YoY Growth+5.6%
Current Streak5 quarters growth
Cumulative Cost Basis at Other Companies
Frequently Asked Questions
- What is ResMed's cumulative cost basis?
- ResMed (RMD) reported cumulative cost basis of $1.35B in Q1 2026.
- How has ResMed's cumulative cost basis changed year-over-year?
- ResMed's cumulative cost basis increased by 9.2% year-over-year, from $1.23B to $1.35B.
- What is the long-term trend for ResMed's cumulative cost basis?
- Over 4 years (2021 to 2025), ResMed's cumulative cost basis has grown at a 3.7% compound annual growth rate (CAGR), from $1.09B to $1.26B.
- What does cumulative cost basis mean?
- The original total cost of assets or liabilities before any accounting adjustments.